Application of ASCO Value Framework to Treatment Advances in Hepatocellular Carcinoma.

Emerson Y Chen Madeline M CookChristopher DeigAsad ArastuVinay PrasadNima NabavizadehCharles D LopezAdel Kardosh

Published in: JCO oncology practice (2021)

The nine FDA-approved therapies for HCC have higher mean NHB score than those that were not FDA-approved. The application of ASCO-NHB v2 and other proposed value frameworks could examine data of future therapies for HCC through a patient-oriented approach.

Keyphrases

drug administration
case report
electronic health record
current status
combination therapy
deep learning
data analysis